ORF » Species Summary » Homo sapiens » Reactome » Regulation of TNFR1 signaling

ORF cDNAクローンを検索してください

検索サポート

以下のような検索ワードを入力できます：

  • Entrez Gene ID (e.g. 7157)
  • gene symbol (e.g. TP53)
  • gene name (e.g. tumor protein p53)
  • gene synonyms (e.g. FLJ92943)
  • Ensembl ID (e.g. ENSG0000141510)
  • Accession No. (e.g. NM_000546)
  • 種名は、キーワードの後に ”キーワード[species:$species]” という形式で入力できます。ここで、$speciesは種の名称（ヒトやラットなど）、または分類群id　（9606など）を入力します。

さらに検索するには こちらをクリック.


Homo sapiens (human) Regulation of TNFR1 signaling (provided by Reactome)

Browse by Letter Index, Genomic Locus

33 gene

The longest variant of each gene is displayed. Click the see gene variants link to see all gene variants.


Gene Symbol Full Name
RNF31 ring finger protein 31
RACK1 receptor for activated C kinase 1
RIPK1 receptor interacting serine/threonine kinase 1
CHUK conserved helix-loop-helix ubiquitous kinase
OTUD7B OTU deubiquitinase 7B
USP2 ubiquitin specific peptidase 2
TAX1BP1 Tax1 binding protein 1
SPPL2B signal peptide peptidase like 2B
TNFRSF1A TNF receptor superfamily member 1A
USP4 ubiquitin specific peptidase 4
UBC ubiquitin C
UBA52 ubiquitin A-52 residue ribosomal protein fusion product 1
OTULIN OTU deubiquitinase with linear linkage specificity
XIAP X-linked inhibitor of apoptosis
CASP8 caspase 8
TRADD TNFRSF1A associated via death domain
TNFAIP3 TNF alpha induced protein 3
BIRC3 baculoviral IAP repeat containing 3
TRAF1 TNF receptor associated factor 1
RPS27A ribosomal protein S27a
SHARPIN SHANK associated RH domain interactor
TRAF2 TNF receptor associated factor 2
CLIP3 CAP-Gly domain containing linker protein 3
CYLD CYLD lysine 63 deubiquitinase
RBCK1 RANBP2-type and C3HC4-type zinc finger containing 1
SPPL2A signal peptide peptidase like 2A
UBB ubiquitin B
TNF tumor necrosis factor
BIRC2 baculoviral IAP repeat containing 2
IKBKG inhibitor of nuclear factor kappa B kinase subunit gamma
IKBKB inhibitor of nuclear factor kappa B kinase subunit beta
USP21 ubiquitin specific peptidase 21
MADD MAP kinase activating death domain
ORF
overview_MB_2022